Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Washington, District of Columbia Clinical Trials

A listing of Washington, District of Columbia clinical trials actively recruiting patient volunteers.

RESULTS

Found (20) clinical trials

DC Longitudinal Study on Aging and Specimen Bank

These studies will examine the feasibility of using various biochemical assays in blood, and/or cerebrospinal fluid, genetic testing, cognitive status assessments, and lifestyle questionnaires to aid in the ante-mortem diagnosis of Alzheimer's and other neurodegenerative diseases. Subjects have 2 options for participation. They may solely participate in the main study ...

Phase N/A

1.32 miles

Learn More »

Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)

Eligibility will be determined based on historical local pathology and medical record information. Informed consent will be obtained and eligible subjects will be treated with the Cryoballoon Focal Ablation System (CbFAS) at baseline. Subjects will return every 3 months +/- 6 weeks for repeat treatment for up to 12 months ...

Phase N/A

1.32 miles

Learn More »

CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic Severe Calcific Aortic Stenosis Requiring Aortic Valve Replacement

A prospective, single-arm, controlled, multicenter study. Additional subjects may be enrolled in a bicuspid registry.

Phase N/A

1.62 miles

Learn More »

Identification of the Pre-exposure Prophylaxis (PrEP) Cascade for Women.

Pre-exposure prophylaxis (PrEP) with daily tenofovir-emtricitabine (TFV/FTC) reduces transmission of human immunodeficiency virus (HIV) by up to 92%, however PrEP is underutilized, especially in women. Women account for nearly 20% of new HIV diagnoses-- most via heterosexual transmission; African-American women and women of color are disproportionately affected. PrEP is recommended ...

Phase N/A

1.62 miles

Learn More »

Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery

This is a feasibility study which will evaluate the effects of pre-operative treatment of DCIS of the breast with palbociclib. Patients with biopsy-proven DCIS are eligible for the study. There will be 2 independent and unrelated study groups of 12 patients each, for a total of 24 patients Group A, ...

Phase

3.03 miles

Learn More »

The Genetic Education for Men Trial: Web-Based Education vs. Standard Care

Aim 1: Develop a web-based intervention to increase genetic counseling/testing uptake in men at high risk for carrying a BRCA mutation. Aim 2: Evaluate the impact of the web-based intervention (WI) vs. usual care (UC) Aim 3: Examine the behavioral and psychosocial impact of BRCA testing in men from BRCA ...

Phase N/A

3.03 miles

Learn More »

Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

A Phase 3, international, multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of glepaglutide subcutaneous (SC) injections in patients with short bowel syndrome (SBS).

Phase

3.03 miles

Learn More »

Low-Fat Vegan Diet Versus a Mediterranean Diet on Body Weight

In a 36-week cross-over trial, overweight adults will consume a low-fat vegan diet and a Mediterranean diet in two separate 16-week phases. Changes in body weight will be the primary dependent variable. In addition, plasma lipid concentrations, insulin sensitivity, and postprandial metabolism will also be assessed and changes over time ...

Phase N/A

4.08 miles

Learn More »

Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

This study will look at the change in body weight from the start to the end of the study. Researchers will compare the weight loss in people taking semaglutide (a new medicine) to people taking "dummy" medicine. In addition to taking the medicine, participants will also have talks with study ...

Phase

4.41 miles

Learn More »

Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis

This study is a Phase 2, open-label study of the combination of a single dose-level of AZ (Zithromax) plus CQ given weekly as a prophylaxis against CQ-resistant P falciparum in healthy adults. After signing informed consent, subjects will undergo screening procedures between Day -77 to Day -18. If enrolled, subjects ...

Phase

6.0 miles

Learn More »